{"data":{"id":"us-md/md.-code-health-general-21-2a-04","jurisdiction":"us-md","citation":"Md. Code, Health - General § 21–2A–04","heading":"","body":"(a) The Secretary, in consultation with the Board, shall adopt regulations to carry out this subtitle.\n(b) The regulations adopted by the Secretary shall:\n(1) Specify the prescription monitoring data and naloxone medication data required to be submitted under § 21–2A–03 of this subtitle;\n(2) Specify the electronic or other means by which information is to be submitted:\n(i) Without unduly increasing the workload and expense on dispensers; and\n(ii) In a manner as compatible as possible with existing data submission practices of dispensers;\n(3) Specify that the information be submitted by dispensers once every 24 hours;\n(4) Specify that the Program:\n(i) Shall provide the information technology software to dispensers necessary to upload prescription drug monitoring data and naloxone medication data to the Program; and\n(ii) May not impose any fees or other assessments on prescribers or dispensers to support the operation of the Program;\n(5) Identify the mechanism by which:\n(i) Prescription monitoring data are disclosed to a person, in accordance with § 21–2A–06 of this subtitle; and\n(ii) Naloxone medication data are disclosed to a person, in accordance with § 21–2A–06.1 of this subtitle;\n(6) Identify the circumstances under which a person may disclose prescription monitoring data or naloxone medication data received under the Program;\n(7) Specify the process for the Program’s review of prescription monitoring data and naloxone medication data and reporting of:\n(i) Possible misuse or abuse of a monitored prescription drug under § 21–2A–06(c) of this subtitle; or\n(ii) A possible violation of law or possible breach of professional standards under § 21–2A–06(d) of this subtitle;\n(8) Establish requirements for Program retention of prescription monitoring data and naloxone medication data for 3 years; and\n(9) Require that:\n(i) Confidential or privileged patient information be kept confidential; and\n(ii) Records or information protected by a privilege between a health care provider and a patient, or otherwise required by law to be held confidential, be filed in a manner that, except as otherwise provided in §§ 21–2A–06 and 21–2A–06.1 of this subtitle, does not disclose the identity of the person protected.","path":["Article - Health - General"],"source_url":"https://mgaleg.maryland.gov/mgawebsite/Laws/StatuteText?article=ghg\u0026section=21-2A-04","current_through":"2026-01-01","vintage":"","retrieved_at":"2026-09-14T19:58:48Z","sha256":"21fdde0eb1909575a6c0a48f89860b71b5269ae9229e85247f3ee9ca41aefff8","source_id":"us-md","stale":false,"prev":"us-md/md.-code-health-general-21-2a-03","next":"us-md/md.-code-health-general-21-2a-04.1"},"notice":"GroundRules: Original legal text. Not legal advice."}